The nature of the transmitter mediating vasoconstriction of guinea-pig submucosal arterioles following sympathetic nerve stimulation was studied.
Introduction
Although noradrenaline (NA) is present in high concentrations in sympathetic nerve terminals, NA does not mediate all the postjunctional responses elicited by sympathetic nerve stimulation (Ambache & Zar, 1971; Burnstock, 1986) . Studies on guinea-pig submucosal arterioles have shown that both the underlying changes in membrane potential (excitatory junction potentials, ej.ps) and vasoconstrictions following short trains of low or high frequency stimulation of the sympathetic nerves are unaffected by ax-adrenoceptor antagonists (Hirst & Neild, 1980; 1981; Shen et al., 1990) . Paradoxically these vessels constrict when low concentrations of NA are applied exogenously, and NA released from the sympathetic nerves following electrical stimulation acts through prejunctional a2-adrenoceptors to depress transmitter release. Hirst & Neild (1980; 1981) suggested that the xadrenoceptor resistant responses in this vessel were due to the action of NA through a novel y-adrenoceptor. In a number of other arteries cx-adrenoceptor antagonist resistant contractions following sympathetic nerve stimulation have been recorded (Muramatsu et al., 1989; Sjoblom-Widfeldt et al., 1990; Brizzolara & Burnstock, 1990) . These are thought to be due to ATP, which is co-released with NA, acting through P2x-purinoceptors because they are abolished following desensitization of P2x-purinoceptors with the stable adenosine 5'-triphosphate (ATP) analogue cxj-methylene ATP (Ramme et al., 1987; Hirst & Jobling, 1989; Evans & Cunnane, 1992) . Recently the trypanocide, suramin, has been demonstrated to be an antagonist at the P2-purinoceptor in the rodent vas deferens (Dunn & Blakeley, 1988; Kugelgen & Starke, 1989 ) and the guinea-pig taenia caeci (Den Hertog et al., 1989; Hoyle et al., 1990) . ' Author for correspondence.
The aims of the present study were three fold: (1) to determine if an al-adrenoceptor antagonist sensitive contraction can be recorded in this vessel in response to nerve stimulation using 100 pulses at 10 Hz, parameters that to our knowledge have revealed an al-adrenoceptor-mediated contraction in all arteries studied; (2) to establish if the prazosin-resistant contraction is due to the activation of y-adrenoceptors by NA or the activation of P2x-purinoceptors by ATP; (3) to test the specificity of suramin for antagonizing P2-purinoceptors.
Methods
Submucosal plexus preparations were obtained from the small intestine of guinea-pigs (150-250 g); methods of tissue preparation and intracellular recording from submucosal neurones were as detailed previously (Surprenant, 1984) . Tissues were superfused at 3-4 ml min-' with a physiological solution of the following composition (mM): NaCl 126, NaH2PO4 1.2, MgCl2 1.2, CaCl2 2.5, KCl 5, NaHCO3 25, glucose l1; gassed with 95% 02 and 5% CO2. Temperature was maintained at 34-36'C.
The perivascular nerves on the surface of the arterioles were stimulated electrically through blunt glass microelectrodes (tip diameter 20-50 jim) filled with physiological saline and placed lightly on the surface of the arteriole about 1 mm away from the recording site. In contractility experiments, magnesium was omitted from the solution because constrictions in response to nerve stimulation or exogenously applied agonists were greater; similar observations have been reported in a variety of other blood vessels (Ramme et al., 1987; Evans & Cunnane, 1991) . Test agents were added to '." Macmillan Press Ltd, 1992 the superfusion medium to give the required final concentration.
Nerve stimulation (100 pulses at 10 Hz, 0.2 ms pulse width at 40 V from a Grass S88 stimulator) was delivered at 5 min intervals with 5-8 sets of these stimuli being given before any drug application; the amplitudes of successive control responses varied by less than ± 5%. Vasoconstrictor substances were applied for a duration of 2-5 min every 20 or 30 min with 2-4 such applications being given before any drug application. Data are expressed as a percentage of the response before drug application; all values are mean ± s.e.mean. Tests of significance were by Student's t test; P < 0.05 was considered significant, n = number of animals except where stated otherwise.
Vessel diameter recordings
Changes in the outside diameter of the arterioles following nerve stimulation or the application of agonists were monitored by the Diamtrak system (Neild, 1989) . This system can track the diameter of small vessels by on-line computer analysis of TV images with an Imaging Technology PCVisionPlus frame grabber board (Imaging Technology Inc., Woburn, Mass., U.S.A.) in an IBM PC/AT computer. The result was converted to an analog signal which was displayed on a conventional chart recorder. The data were sampled at 10-20 Hz and the resolution of the system was less than 1 tim. (Lindvall & Bjorklund, 1974; Furness & Costa, 1975 
Results

Contractility studies
Electrical stimulation of guinea-pig submucosal arterioles with trains of 100 pulses at 10 Hz every 5 min evoked reproducible vasoconstrictions measured as changes in the outside diameter of the vessel. The diameter of the arteriole quickly returned to its control value on cessation of stimulation. In the majority of experiments the vasoconstriction could be resolved into a rapidly rising transient peak within the first 30-40 s followed by a smaller amplitude maintained constriction (Figure 1 ). Electrically evoked responses were abolished by tetrodotoxin (0.3 DIM, n = 8).
Effrcts of' a-adirenoceptor antagonists The a1-adrenoceptor antagonist, prazosin (0.1 !iM), had no effect on either the resting tone of the vessel, or the nerve-evoked vasoconstriction measured either at the initial peak amplitude or during the maintained plateau phase (Figure 1 ). Contractions elicited by the selective ax,-adrenoceptor agonist, phenylephrine (1 IIM), of similar amplitude to the nerve-evoked constriction were abolished by 0.1I M prazosin (n = 5) (see also Vanner et al., 1990) .
The a,-adrenoceptor antagonist, idazoxan (0.1 Mm), significantly increased both the initial peak amplitude of the neurally evoked vasoconstriction as well as the maintained plateau phase (Figure 2 ). The potentiation of the nerveevoked constriction by idazoxan was unaffected by prazosin (0.1 plM) (peak height, idazoxan 165 ± 22%, idazoxan + prazosin 184 ± 36%; maintained vasoconstriction, idazoxan 242 ± 21%, idazoxan + prazosin 204 ± 35%, n = 4). on nerve-evoked contractions from normal and reserpinized guineapigs. Results from normal animals (n = 5) were quantified both as initial peak amplitude and the amplitude of the maintained response. Peak amplitude only was measured in arterioles from reserpinized animals because these preparations did not show two distinct phases of constriction (n = 5). Data are plotted as mean ( ± s.e.mean, vertical bars) of the % of the nerve evoked constriction before idazoxan application (control, open columns; idazaxon, solid columns). Periods of nerve stimulation (NS) are marked by bars. **P<0.001.
Reserpinization Dense catecholamine fluorescence was present in all control preparations of the submucosal plexus ( Figure 3a ) (see also Furness & Costa, 1987) . No catecholamine fluorescence was observed following glyoxylic acid staining of submucosal plexus preparations from reserpine pretreated guinea-pigs (Figure 3b ) indicating an apparent absence of tissue noradrenaline. However, nerve evoked constrictions of similar magnitude to control were still recorded following reserpine treatment. Control vasoconstrictions were 21.2 ± 2.4 tm and vasoconstrictions in reserpinized animals were 28 ± 3.2 jlm (n = 8 arterioles from 4 animals). In contrast to control tissues, these responses were not potentiated by idazoxan (0.1I M, n = 6 arterioles from 4 animals, Figure  2b ).
Effects of the adrenergic neurone blocker guanethidine Guanethidine (3 jM) abolished vasoconstrictions evoked by nerve stimulation, an effect reversed by the concomitant application of amphetamine (3 jM, n = 4, Figure 4) . A similar reversal of the effects of guanethidine by amphetamine has been shown in the guinea-pig vas deferens (Brock & Cunnane, 1988) and rabbit jejunal artery (Evans, 1990) . The mechanism of action of amphetamine was not examined in this study; however, Brock & Cunnane (1988) suggest that amphetamine probably acts by displacing guanethidine from sympathetic nerve terminals. The abolition of the response to electrical stimulation with the adrenergic neurone blocker, guanethidine, further demonstrates that the nerve-evoked, a-adrenoceptor antagonist-resistant vasoconstriction was generated by the release of transmitter from sympathetic nerves.
Determination of the a-adrenoceptor antagonist resistant component of constriction In a number of arteries where aadrenoceptor antagonist resistant contractions have been reported the residual contraction appears to be due to the activation of P2x-purinoceptors by ATP (for review, see von Kugelgen & Starke, 1991 baseline on prolonged application but declined to a maintained level; the amplitude of the maintained vasoconstriction elictied by mATP (1 AM) or DADPP (1 AM) was 30.6 ± 7.3% and 30.7 ± 1.9% of the peak response respectively (n = 3, Figure 5 ). The diameter of the vessel returned to control values within 3-5 min of washout of mATP or DADPP.
The putative P2-purinoceptor antagonist, suramin (100 AM), had no effect on the resting diameter of the vessel or the vasoconstriction to exogenously applied NA (3 LM), but abolished both the nerve-evoked constriction and the response to exogenously applied ATP (3 AM, Figure 6 ). Constrictions evoked by nerve stimulation or the exogenous application of ATP were partially reversed following a 20 min washout period. Suramin also abolished the potentiated vasoconstrictions obtained following the removal of the M2-autoinhibitory input with idazoxan (n = 3), as well as the neurally evoked constrictions recorded in reserpinetreated tissues (n = 2). These results strongly suggest that sympathetic vasoconstriction in submucosal arterioles is mediated solely by the action of ATP. , 1985) . These two events were used to assess further the specificity of suramin as an antagonist at the P2x-purinoceptor. Suramin had no effect on the amplitude (control 18.7 ± 1.6 mV, suramin 18.9 ± 3.2 mV, P = 0.94, n = 4) or the time constant of decay of nicotinic fast e.p.s.ps (control 21.4 + 5.1 ms, suramin 17.2 ± 4.1 ins, P = 0.49) evoked by nerve stimulation (0.1 Hz) when the membrane potential was held at -90 mV so that action potential initiation was prevented. At the resting membrane potential (-45 to -65 mV) many e.p.s.ps were suprathreshold for initiation of action potentials; suramin had no effect on action potential threshold, amplitude or duration (Figure 7a) . Previous studies have characterized the i.p.s.p. recorded in normal preparations as being due to the action of NA released from sympathetic nerves onto a2-adrenoceptors on the submucosal neurones (North & Surprenant, 1985) , although a non-adrenergic i.p.s.p. has also been observed (Mihara et al., 1987; Bornstein et al., 1988) . In this study i.p.s.ps recorded in control animals were abolished by 1 pM idazoxan. Suramin had no effect on the amplitude of the i.p.s.p. (control 30 ± 4.1 mV, suramin 30 ± 3 mV, n = 4), or the time taken for the i.p.s.p. to decay by 50% (control 750 ± 330 ms, suramin 5 min 900 ± 380 ms, P = 0.73; suramin 10 min 1000 ± 350 ms, P = 0.51, n = 4; Figure 7b ). After reserpine treatment noradrenergic (ie. idazoxansensitive) i.p.s.ps were not recorded in neurones which were hyperpolarized by superfusion with the M2-adrenoceptor agonist, UK14304; it has been shown previously that all submucosal neurones which are hyperpolarized by 02-adrenoceptor agonists also exhibt noradrenergic i.p.s.ps in response to nerve stimulation (Surprenant & North, 1988) . These observations further strengthen the conclusion that reserpine treatment does produce complete functional depletion of NA from sympathetic nerves in the submucosal plexus.
Intracellular recordings from submucosal neurones
Intracellular recordings from submucosal arterioles Idazoxan (0.1 JAM) increased the steady-state amplitude of e.j.ps in a train (n = 3, Figure 8a ). Suramin (100 JAM) abolished all ej.ps recorded in control solution (n = 2) or in the presence of idazoxan (n = 2, Figure 8c ). The blockade of the e.j.ps by suramin was only partially reversed (to approximately 50% of control amplitude) after 15-20 min of wash (Figure 8d ).
Discussion
The vasoconstriction of guinea-pig submucosal arterioles evoked by 100 pulses at 10 Hz was unaffected by the aoadrenoceptor antagonist, prazosin. This is despite the fact that both in the present and a previous study (Shen et al., 1990 ) NA has been demonstrated to be released from sympathetic nerves in the submucosal plexus following nerve stimulation and activates inhibitory prejunctional M2-adrenoceptors on both submucosal and sympathetic neurones. Moreover, vasoconstrictions of similar amplitude to the neurogenic response can be evoked by the exogenous application of low concentrations of a-adrenoceptor agonists (Shen et al., 1990; Vanner et al., 1990 ). Resistance to a-adrenoceptor blockade is not a new phenomenon and has been described in many vascular tissues (for review, see Burnstock, 1990 ). However it is usually only a component that is resistant. Purely aresistant contractions in response to short trains of low frequency stimuli have been reported in two vessels, the rabbit jejunal artery (Ramme et al., 1987; Evans & Cunnane, 1992) and the rabbit saphenous artery ; even in these vessels a substantial component of the contraction can be demonstrated to be noradrenergic in origin following prolonged high frequency stimulation. The present study on the guinea-pig submucosal arterioles has failed to reveal an a-adrenoceptor-sensitive component of the vasoconstriction at stimulation parameters that have demonstrated a substantial noradrenergic contraction in all arteries studied to date. It would thus seem that neurally released NA fails to reach a concentration sufficient to activate postjunctional a-adrenoceptors and mediate vasoconstriction of submucosal arterioles. These results also support the idea (Hirst & Edwards, 1989) found extrajunctionally and that another receptor at the sympathetic neuroeffector junction mediates the response to sympathetic nerve stimulation.
An important functional role for NA following sympathetic nerve stimulation was demonstrated with the competitive a2-adrenoceptor antagonist, idazoxan. Contractile responses and e.j.ps were potentiated in the presence of idazoxan indicating that NA acts through prejunctional a2-adrenoceptors to depress transmitter release. Potentiation of nerveevoked transmitter release by a2-adrenoceptor antagonists has been reported for a number of blood vessels and other tissues (Starke, 1977; 1987; Mishima et al., 1984) . The potentiation of the contractile response, in particular the maintained component, suggests that the decline of the nerve-evoked vasoconstriction following the transient peak response can be explained at least in part by a2-adrenoceptor activation.
Results obtained with reserpine provide considerable evidence that a transmitter other than NA is responsible for mediating vasoconstriction of submucosal arterioles following sympathetic nerve stimulation. Following reserpine treatment, vasoconstrictions elicited by nerve stimulation were of similar magnitude to those recorded in control tissues. Our results are similar to those in the guinea-pig vas deferens (Kirkpatrick & Burnstock, 1987) and rabbit saphenous artery , in which reserpine did not significantly alter the magnitude of the prazosin-resistant (presumably purinergic) nerve-evoked contraction. The functional depletion of NA from the sympathetic nerves innervating the submucosal plexus was demonstrated both by the absence of catecholamine fluorescence and by the failure to record idazoxan-sensitive noradrenergic i.p.s.ps in submucosal neurones following reserpine treatment. Previous studies in the guinea-pig have shown that the reserpine pretreatment regime used in the present study depletes the NA content of the vas deferens, a tissue with a dense sympathetic innervation, by more than 95% (Wakade & Krusz, 1972; Kirkpatrick & Burnstock, 1987) , and abolishes the potentiating effects of the a2-adrenoceptor antagonist, yohimbine (Brock et al., 1990) . Similarly, NA-mediated electrophysiological responses recorded from the rat brain slice preparation are abolished following reserpine treatment (Pan & Williams, 1989) .
In a number of vessels where (i-antagonist resistant responses have been recorded, they have been shown to be due to the activation of P2x-purinoceptors by ATP co-released with NA from sympathetic nerves (von Kugelgen & Starke, 1985; Brizzolara & Burnstock, 1990; Sjoblom-Widfeldt et al., 1990) . In the present study, arteriolar constrictions were evoked in response to the exogenous application of ATP, mATP and DADPP. The finding that mATP and DADPP were more potent than ATP is in keeping with the pharmacological profile of the P2x-purinoceptor (see Burnstock, 1991) .
In other studies (MacKenzie et al., 1988; Evans & Cunnane, 1992 ) mATP and DADPP produced contractions that faded completely in the continued presence of the agonist. This full desensitization of the response has been used to quantitate the degree to which the neurally mediated contraction is due to the activation of P2x-purinoceptors. In the present study neither mATP nor DADPP produced a vasoconstriction that fully desensitized during the maintained presence of these agonists. Therefore mATP and DADPP were considered unsuitable for adquately characterizing the P2x-purinoceptor mediated response in submucosal arterioles.
Suramin abolished nerve evoked ej.ps and constrictions of submucosal arterioles elicited by either exogenously applied ATP or sympathetic nerve stimulation, but had no effects on the arteriolar constriction to exogenously applied NA, nor on the noradrenergic i.p.s.ps or nicotinic e.p.s.ps recorded from submucosal neurones. A similar specificity of suramin in antagonizing P2-purinoceptors has been reported in the rodent vas deferens and guinea-pig taenia caeci (Dunn & Blakeley, 1988; Den Hertog et al., 1989; von Kugelgen et al, 1989a) . The finding that suramin has no effect on the noradrenergic i.p.s.p. taken with the lack of effect on the constriction to exogenoulsy applied NA, implies not only that suramin does not affect the postjunctional response to NA but also has no effect on transmitter release from sympathetic nerves. The lack of prejunctional actions of suramin on transmitter release from sympathetic nerves has been reported from studies of the overflow of tritiated NA following nerve stimulation in the mouse vas deferens (von Kugelgen et al., 1989b) . In the present study responses to ATP (3 tiM) and nerve stimulation were both abolished, suggesting that in submucosal arterioles, suramin is an effective antagonist of The results obtained with suramin, taken together with the agonist potencies of ATP, mATP and DADPP, are consistent with the view that vasoconstrictions and the underlying changes in membrane potential, the ej.ps, following nerve stimulation are mediated through the action of ATP or a structurally related purine nucleotide through P2X-purinoceptors. These data, particularly those from reserpinized tissues, provide no evidence to suggest that the a-adrenoceptor-resistant vasoconstriction and underlying changes in membrane potential are due to the activation of y-adrenoceptors by NA as suggested by Hirst & Neild (1980 , 1981 . In summary we have described for the first time a blood vessel in which all the postjunctional responses evoked by stimulation of the sympathetic nerves are mediated by the activation of P2x-purinoceptors by ATP or a related purine nucleotide. Submucosal arterioles comprise the resistance vessels of the gastrointestinal microcirculation and have been estimated to contribute up to 40% of the total mesentericsplanchnic resistance (Lundgren, 1984; Parks & Jacobsen, 1987; Granger et al., 1987) , as well as contributing significantly to the maintenance of systemic blood pressure. Thus purinergic transmission may play a major role in the neural regulation of the gastrointestinal microcirculation. The functional role of neurally released NA in submucosal arterioles appears to be restricted to its prejunctional modulation of transmitter release.
